
Kalipso Chalkidou
Director, Health Financing and Economics at World Health Organization (WHO)
Director, Health Financing & Economics @WHO; formerly @GFATM and @CGD; Visiting Professor at Imperial College London. Tweets personal - RTs NOT endorsements.
Articles
-
1 month ago |
linkedin.com | Kalipso Chalkidou
Punjabi performers at the end of Day 1... Fifteen years ago, Dr Sundararaman, the founding director of India’s National Health Systems Resource Centre, a think tank under the MoHFW, invited me to give a lecture about NICE, the National Health Service’s Health Technology Assessment body. It was one of my first “missions” as the head of 3-person team, NICE International, set up to share experiences on evidence informed policy making with governments around the world.
-
1 month ago |
gh.bmj.com | Kalipso Chalkidou |Richard J. Sullivan
Introduction‘[power’s] success is proportional to its ability to hide its own mechanisms’. The lancet commission: Women, power and cancer investigates, exposes and challenges the prevailing asymmetries of power in relation to cancer in three domains: Decision-making, knowledge and economics.
-
2 months ago |
devex.com | Kalipso Chalkidou
A recent review of four key climate funds offers a blueprint applicable to the global health financing landscape. In October 2024, Brazil’s G2 Presidency’s Sustainable Finance Working Group published a review of several vertical climate and environmental funds. Authored by independent experts, the report examined four major multilateral funds, offering actionable recommendations to streamline their operations and boost their ability to leverage additional public and private finance.
-
Sep 27, 2024 |
linkedin.com | Kalipso Chalkidou
It is not often that eight major international organisations and 20+ country representatives from government and civil society to mitigate against donor fund volatility and proactively to plan for effective and equitable transitioning away from aid and progressing towards #UHC.
-
Aug 15, 2024 |
reliefweb.int | Kalipso Chalkidou |Victoria Fan
Attachments Download Report (PDF | 1022.73 KB) By Kalipso Chalkidou, Victoria Fan and Clemence LandersThe grants model: how we got hereOver the last twenty plus years, global health has benefited from the emergence of new financing models and “global health initiatives” (GHIs), including Gavi, the Vaccine Alliance and the Global Fund to Fight Aids, Tuberculosis, and Malaria.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 4K
- Tweets
- 5K
- DMs Open
- No

"If health financing strengthening is the pillar supporting sustainable UHC, then building and utilizing health financing data is its backbone." Looking forward to working with @WBG_Health and Japan to operationalise the Hub https://t.co/dRfJWS364A

As Dr Tedros says: "UHC is ultimately a political choice". Parliamentarians are crucial in making UHC happen - thank you @UHC2030 and UNITE 🙏🙏🙏

👉 Are you in Washington attending the @WorldBank and @IMFNews Spring Meetings and the #GlobalParliamentaryForum2025? Don’t miss out on UNITE and @UHC2030 side event happening today! 📍 Room L-101, IFC Headquarters 📝 Still time to register: https://t.co/MI322msSUp https://t.co/BKUkkL3mgJ

"...reshoring is neither fast nor inexpensive. Building a new facility can take 5–10 years and cost up to $2 billion. Meeting U.S. demand for generics, which exceeds 187 b pills annually, would require 27 times the manufacturing capacity currently needed for branded products."